Research Library

The authors examine a proposal for new human embryo and embryoid guidelines, writing that before conducting any research beyond day 14, scientists must develop clear, thoughtful and culturally sensitive guidelines that include limitations and oversight procedures to ensure that science responds to societal needs and values.

Kuwait has developed and earned a reputation as a mediator in regional affairs, carefully balancing competing regional pressures in light of its own pragmatic interests.

The recent shift toward legalization has not been enough to undo the racism endemic to U.S. cannabis policy. The authors lay out policies to improve equity and erase the racist legacy of prohibition.

This journal article explores why the public and stakeholders should help develop guidelines and policies governing scientific practices for controversial biomedical research issues, such as genetically editing human embryos.

The authors explore a causal relationship between the 2017 tax reform and a decline in wealth inequality.

Although Texans broadly support relaxing cannabis laws and other criminal justice reforms, state leaders continue the war on drugs and other policies that propagate systemic racism, writes fellow Katharine Neill Harris.

The unproven stem cell intervention industry is a worldwide, direct-to-consumer market where clinics offer stem cells or stem cell-derived components to patients with little to no scientific or clinical basis. In this paper, the authors call for the establishment of a World Health Organization Expert Advisory Committee on Regenerative Medicine to tackle this issue and provide guidance. Stem Cell Reports: https://doi.org/10.1016/j.stemcr.2021.05.004

The authors sought to develop and test a tool that accurately predicts the unique financial burden to individual patients undergoing treatment for breast cancer. JCO Clinical Cancer Informatics, an American Society of Clinical Oncology Journal

The authors assess the impact of Mexico's 2014 energy reform on consumer welfare.

Health policy experts Kirstin Matthews and Rekha Lakshmanan compare the three COVID-19 vaccines now available from Pfizer, Moderna and Johnson & Johnson and, in a separate infographic, provide an overview of Operation Warp Speed.